[1] 胡盛寿, 高润霖, 刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.
[2] Losner S, Volk BW, Wilensky ND. Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate[J].AMA Arch Intern Med,1954,93(2): 231-245.
[3] Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G.Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain[J].Thromb Haemost,1995,73(3): 374-379.
[4] 刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志,2011,19(8):701-743.
[5] Gabir MM, Hanson RL, Dabelea D, et al.The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes[J]. Diabetes Care,2000,23(8): 1108-1112.
[6] 胡文斌, 张婷, 史建国, 等. 男性吸烟与高血压病的剂量-反应关系[J].中华心血管病杂志,2014,42(9): 773-777.
[7] 高洁, 耿晓雯, 吕中华,等. 冠状动脉多支病变的危险因素分析[J]. 解放军医学院学报,2016,37(5):413-416,420.
[8] Sharma RK, Sharma RK, Voelker DJ, et al.Cardiac risk stratification: role of the coronary calcium score[J].Vasc Health Risk Manag,2010, 6: 603-11.
[9] Rampidis GP, Benetos G, Benz DC, et al.A guide for Gensini Score calculation[J]. Atherosclerosis, 2019,287:181-183.
[10] Signorelli SS, Fiore V, Malaponte G.Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review)[J].Int J Mol Med,2014,33(4): 777-83.
[11] 刘梅颜, 胡大一, 闫丽, 等. 高水平纤维蛋白原与冠状动脉狭窄严重程度相关性探讨[J].中华内科杂志,2004, (11): 24-27.
[12] Foiles N, Green D, Schreiner PJ,et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study,2013 .
[13] Finegold JA, Asaria P, Francis DP.Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations[J]. Int J Cardiol, 2013,168(2):934-945.
[14] Marshall RJ, Milne RJ, Lynn R, et al.Quantifying the effect of age on short-term and long-term case fatality in 14,000 patients with incident cases of cardiovascular disease[J]. Eur J Cardiovasc Prev Rehabil,2008,15(2): 179-184.
[15] Fritz J, Edlinger M, Kelleher C, et al.Mediation analysis of the relationship between sex, cardiovascular risk factors and mortality from coronary heart disease: Findings from the population-based VHM&PP cohort[J]. Atherosclerosis, 2015,243(1):86-92.
[16] 吴舒窈, 刘艳, 宋倩. 冠心病发病及预后的影响因素研究[J]. 中国全科医学,2018,21(29):3562-3570.
[17] Pischon T, Girman CJ, Sacks FM,et al.Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men[J]. Circulation,2005,112(22): 3375-3383.
[18] Reinhart WH. Fibrinogen--marker or mediator of vascular disease[J]. Vasc Med,2003,8(3): 211-216.
[19] Tousoulis D, Papageorgiou N, Androulakis E, et al. Fibrinogen and cardiovascular disease: genetics and biomarkers[J]. Blood Rev, 2011,25(6):239-245. |
